Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,906	344	86	40	112	100
Market Cap Growth	408.78%	298.31%	118.11%	-64.73%	12.29%	-37.55%
Enterprise Value	1,848	302	56	-7	40	51
Last Close Price	22.15	5.35	1.76	0.85	2.41	3.56
PB Ratio	23.05	10.56	2.23	0.71	1.16	1.39
P/TBV Ratio	26.65	10.56	2.23	0.71	1.16	1.39
Debt / Equity Ratio	0.01	0.03	0.04	0.05	0.04	0.03
Quick Ratio	8.18	1.47	3.96	3.99	7.22	3.65
Current Ratio	8.29	1.54	4.07	4.06	7.36	3.73
Return on Equity (ROE)	-35.82%	-174.85%	-57.02%	-53.90%	-51.08%	-8.37%
Return on Assets (ROA)	-34.87%	-30.09%	-25.63%	-22.50%	-24.61%	-32.33%
Return on Capital Employed (ROCE)	-53.70%	-82.20%	-60.30%	-55.60%	-38.50%	-59.60%
Earnings Yield	-0.79%	-18.12%	-31.32%	-104.39%	-38.55%	-6.00%
FCF Yield	-1.68%	-7.40%	-27.77%	-68.97%	-32.73%	-34.89%
Buyback Yield / Dilution	-34.14%	-26.99%	-3.16%	-11.23%	-41.98%	-0.44%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q